Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Viral Respiratory Tract Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT04610801
What this trial is testing

Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2

Who this might be right for
Covid19
Larkin Community Hospital
Large-scale testing (Phase 3)Study completedNCT05890534
What this trial is testing

Pycnogenol® in Post-COVID-19 Condition

Who this might be right for
Post COVID-19 ConditionLong COVID
University of Zurich 153
Early research (Phase 1)Study completedNCT05677893
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy Participants

Who this might be right for
Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)
Oneness Biotech Co., Ltd. 44
Not applicableStudy completedNCT04838834
What this trial is testing

Monitoring Serologic Response to Severe Acute Respiratory Syndrome-2 (SARS-COV-2)/COVID-19 in Children

Who this might be right for
COVID-19SARS-CoV-2Inflammatory Bowel Diseases
Connecticut Children's Medical Center 472
Not applicableLooking for participantsNCT07545499
What this trial is testing

Physical Functions and Lifestyle Behaviours in Post-COVID-19 Syndrome Based on Circadian Rhythms

Who this might be right for
Post-COVID-19 Syndrome
Hacettepe University 50
Large-scale testing (Phase 3)Ended earlyNCT04642638
What this trial is testing

Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure

Who this might be right for
Coronavirus InfectionSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)COVID-19 Disease
Inovio Pharmaceuticals 1,307
Not applicableWithdrawnNCT04508933
What this trial is testing

Comparison of Extra Vascular Lung Water Index in Covid-19 ARDS and "Typical"ARDS Patients

Who this might be right for
Respiratory Distress Syndrome, AdultVentilation Perfusion MismatchPulmonary Edema+1 more
Istanbul University - Cerrahpasa
Testing effectiveness (Phase 2)Ended earlyNCT04602507
What this trial is testing

Ivermectin in Adults With Severe COVID-19.

Who this might be right for
Covid19Severe Acute Respiratory Syndrome
CES University 75
Not applicableActive Not RecruitingNCT06968104
What this trial is testing

Vagus Nerve Stimulation to the Ear to Improve Symptoms in Post-COVID-19 and ME/CFS

Who this might be right for
Post-COVID / Long-COVIDME/CFS
University of Luxembourg 48
Post-approval studies (Phase 4)Study completedNCT04969250
What this trial is testing

Vaccination for Recovered Inpatients With COVID-19 (VATICO)

Who this might be right for
Covid19
National Institute of Allergy and Infectious Diseases (NIAID) 66
Not applicableUnknownNCT05780450
What this trial is testing

Effectiveness of Transcranial Direct Current in Patients With Persistent COVID-19 With Headaches and Chronic Pain.

Who this might be right for
COVID-19Long COVIDLong Covid19+10 more
Fundación Universidad Católica de Valencia San Vicente Mártir 27
Large-scale testing (Phase 3)Study completedNCT05119855
What this trial is testing

Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)

Who this might be right for
Papillomavirus InfectionsCoronavirus Disease (COVID-19)
Merck Sharp & Dohme LLC 165
Not applicableStudy completedNCT05238415
What this trial is testing

ASAP - Assisted Immediate Augmented Post-/Long-COVID Plan for Patients Infected With COVID-19

Who this might be right for
Long-COVIDPost-COVIDPsychosomatic Disorder+10 more
Prof. Dr. Sonia Lippke 192
Not applicableStudy completedNCT04997915
What this trial is testing

Acute Kidney Injury in Coronavirus Disease-19 (COVID-19) Patients Admitted to the Intensive Care Unit (ICU)

Who this might be right for
Critical IllnessCOVID-19 PneumoniaAcute Kidney Injury
University Hospital, Ghent 1,286
Testing effectiveness (Phase 2)Study completedNCT05126563
What this trial is testing

Randomized Double-Blind Phase 2 Study of Allogeneic HB-adMSCs for the Treatment of Chronic Post-COVID-19 Syndrome

Who this might be right for
Post COVID-19 Syndrome
Hope Biosciences Research Foundation 79
Large-scale testing (Phase 3)UnknownNCT04540185
What this trial is testing

Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19

Who this might be right for
Covid19SARS (Severe Acute Respiratory Syndrome)SARS-CoV Infection+1 more
Biomed Industries, Inc. 3,600
Not applicableStudy completedNCT04998799
What this trial is testing

Practice Variation on Antithrombotics in COVID-19

Who this might be right for
COVID-19 PneumoniaThrombosisCOVID-19 Acute Respiratory Distress Syndrome+1 more
NMC Specialty Hospital 435
Not applicableLooking for participantsNCT07110714
What this trial is testing

Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients

Who this might be right for
Post COVID-19 ConditionPost COVID-19 Condition (PCC)Post COVID-19+2 more
Eggensberger OHG 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07089719
What this trial is testing

Bevacizumab in Post-acute Sequelae of COVID-19 : Efficacy and Safety (Pilot Study)

Who this might be right for
Dyspnea Caused by 2019-nCoV
Assistance Publique - Hôpitaux de Paris 21
Not applicableNo Longer AvailableNCT04366830
What this trial is testing

Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection

Who this might be right for
Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19
Mesoblast International Sàrl
Next Page